“Health-Related Quality of Life in Patients with Metastatic Basal Cell Carcinoma Treated with Cemiplimab: Analysis of a Phase 2 Open-Label Clinical Trial”, J of Skin, vol. 8, no. 1, p. s337, Jan. 2024, doi: 10.25251/skin.8.supp.337.